Haemonetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. 

CEO
Christopher A. Simon
CEOChristopher A. Simon
Employees
3,023
Employees3,023
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1971
Founded1971
Employees
3,023
Employees3,023

HAE Key Statistics

Market cap
3.44B
Market cap3.44B
Price-Earnings ratio
21.44
Price-Earnings ratio21.44
Dividend yield
Dividend yield
Average volume
1.59M
Average volume1.59M
High today
$74.92
High today$74.92
Low today
$71.91
Low today$71.91
Open price
$72.59
Open price$72.59
Volume
1.17M
Volume1.17M
52 Week high
$91.43
52 Week high$91.43
52 Week low
$47.32
52 Week low$47.32

Stock Snapshot

As of today, Haemonetics(HAE) shares are valued at $73.49. The company's market cap stands at 3.44B, with a P/E ratio of 21.44.

On 2025-11-15, Haemonetics(HAE) stock traded between a low of $71.91 and a high of $74.92. Shares are currently priced at $73.49, which is +2.2% above the low and -1.9% below the high.

Haemonetics(HAE) shares are trading with a volume of 1.17M, against a daily average of 1.59M.

In the last year, Haemonetics(HAE) shares hit a 52-week high of $91.43 and a 52-week low of $47.32.

In the last year, Haemonetics(HAE) shares hit a 52-week high of $91.43 and a 52-week low of $47.32.

HAE News

Simply Wall St 2d
Haemonetics: Assessing Valuation After Profit Beat and Completion of Major Buyback

Haemonetics (HAE) just reported its latest quarterly earnings, showing a jump in profitability even though sales dipped compared to the same period last year. T...

Haemonetics: Assessing Valuation After Profit Beat and Completion of Major Buyback
The Motley Fool 7d
SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million

SG Capital Management LLC reduced its holding in Haemonetics Corporation (HAE +1.86%) by 731,892 shares, a position value decline of $59,133,712, per November 0...

SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million

Analyst ratings

82%

of 11 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

People also own

Based on the portfolios of people who own HAE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.